April 13, 2018 09:07 AM EDTUpdated 09:25 AM
Financing

In­ven­ti­va rais­es $44M as it preps for a PhI­II NASH pro­gram, up­com­ing IIb read­out

John Carroll

Editor & Founder

French biotech In­ven­ti­va has raised about $44 mil­lion dol­lars from a group of ven­ture back­ers lured by the po­ten­tial of an up­com­ing late-stage ef­fort …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times